tirzepatide glp 1 agonist Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of | Cardiovascular Diabetology Semaglutide & tirzepatide are transforming
Description
Additionally, for individuals with type 2 diabetes, obesity, and heart failure with preserved ejection fraction, GLP-1 receptor agonists are advised to manage glucose and alleviate heart failure symptoms
Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects
Saxenda is sometimes prescribed off-label for metabolic dysfunction-associated steatohepatitis (MASH)
Since its US FDA approval in June 2021 and subsequent EU and Japan approval in 2022 and 2023, respectively, for chronic weight management, WEGOVY has rapidly gained traction
& Guinney, J
Behavioral treatment of obesity
